+958.0%
MRNA vs PEGA
+14.7%
+943.3%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | PEGA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.8% | -5.8% | +0.9% | -3.2% |
| 7D | -20.9% | -8.1% | -12.8% | -18.9% |
| 30D | -13.3% | -17.6% | +4.4% | -8.8% |
| 3M | +212.6% | -11.1% | +223.7% | +222.5% |
| 6M | +309.0% | -15.1% | +324.2% | +322.0% |
| YTD | +567.3% | -51.4% | +618.7% | +687.7% |
| 1Y | +689.7% | -46.5% | +736.2% | +808.6% |
| 3Y | +157.4% | +13.6% | +143.9% | +128.7% |
| 5Y | -21.7% | -50.4% | +28.6% | -21.2% |
| All | +958.0% | +14.7% | +943.3% | +744.2% |
Cumulative growth
Daily Returns
Daily percentage return beside PEGA.
Daily Out/Under-Performance
Portfolio return minus PEGA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PEGA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded PEGA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling